Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Hikma Pharmaceuticals PLC

HKMPFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$17.30
$0.00(0.00%)
U.S. Market is Open • 14:46

HKMPF News Today: Stay Updated with the Latest Hikma Pharmaceuticals PLC News in Real Time

Find HKMPF news now at Meyka AI. Stay informed with the latest Hikma Pharmaceuticals PLC stocks updates, including price news, market analysis, and expert insights.

Cowen Maintains AZN (AstraZeneca PLC) at Buy on March 18, 2026
📅 10 hours ago

Cowen Maintains AZN (AstraZeneca PLC) at Buy on March 18, 2026

Cowen maintains AZN at Buy on March 18, 2026; AZN analyst rating remains positive with Meyka grade A

Read more
Maintained to Buy for SW Smurfit Westrock Plc by Cowen & Co March 2026
📅 12 hours ago

Maintained to Buy for SW Smurfit Westrock Plc by Cowen & Co March 2026

Cowen & Co maintained Buy on Smurfit Westrock Plc; SW analyst rating reviewed March 2026

Read more
STSR stock $2.62 PNK: tested valuation with Meyka forecast and trading signals
📅 13 hours ago

STSR stock $2.62 PNK: tested valuation with Meyka forecast and trading signals

STSR stock trades at $2.62 on PNK; analysis covers valuation, Meyka grade, and a 12-month forecast

Read more
UBS upgrades AU (AngloGold Ashanti Plc) to Buy March 2026
📅 16 hours ago

UBS upgrades AU (AngloGold Ashanti Plc) to Buy March 2026

UBS upgrades AU to Buy on Mar 24, 2026. AU analyst rating change, market reaction, and investor implications

Read more
ACN Stock Today: $16m BOM Climate Hub Sparks Scrutiny – March 26
📅 19 hours ago

ACN Stock Today: $16m BOM Climate Hub Sparks Scrutiny – March 26

BOM weather controversy meets Accenture’s A$16m Climate Risk Hub. What this means for ACN stock, margins, and near-term catalysts Australian investors should watch.

Read more
After Hours Top Loser: NWRN.SW Newron Pharmaceuticals (SIX) 25 Mar 2026: Oversold
📅 20 hours ago

After Hours Top Loser: NWRN.SW Newron Pharmaceuticals (SIX) 25 Mar 2026: Oversold

NWRN.SW stock slips to CHF14.64 after hours on 25 Mar 2026; technical oversold signal and 1M decline highlight risk and opportunity

Read more
Merck to buy Terns (TERN) NASDAQ for $53 on 25 Mar 2026: earnings catalyst for TERN stock
📅 21 hours ago

Merck to buy Terns (TERN) NASDAQ for $53 on 25 Mar 2026: earnings catalyst for TERN stock

Merck offer lifts TERN stock as earnings loom 25 Mar 2026; Meyka AI forecast and intraday outlook for investors

Read more
Merck Close to $6 Billion Deal to Acquire Terns Pharma, FT Says
📅 1 day ago

Merck Close to $6 Billion Deal to Acquire Terns Pharma, FT Says

Global pharmaceutical giant Merck is reportedly nearing a major acquisition worth nearly $6 billion, according to a Financial Times report. The deal involves U.S.-based biotech company Terns Pharmaceuticals and reflects a broader shift in the healthcare industry as large drugmakers race to strengthen their future drug pipelines. The potential acquisition has already sparked strong reactions…

Read more
PLC.AX Premier1 Lithium (ASX) up 42.86% intraday 25 Mar 2026: catalysts to watch
📅 1 day ago

PLC.AX Premier1 Lithium (ASX) up 42.86% intraday 25 Mar 2026: catalysts to watch

PLC.AX stock jumps intraday to A$0.01 on volume; read intraday drivers, Meyka AI grade and forecast for PLC.AX stock

Read more

HKMPF News FAQ